Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples